Symbol
BeiGene, Ltd.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$238.31
Current price of the stock
$317K
Trading volume of the stock
$25.2B
Market capitalization of the company
Large Cap
Category of market capitalization
44.60%
Long-term growth mean estimate
4.77
Mean analyst rating
34.86%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.31
Total debt to total equity ratio
1.93
Current ratio
82.98%
Gross profit margin
-12.01%
Operating profit margin
-12.01%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-9.81%
Pretax profit margin
-12.12%
Net profit margin
-3.53%
Measures profitability relative to shareholders' equity
-3.59%
ROE excluding intangible assets
-2.08%
Measures profitability relative to total assets
-3.35%
Measures profitability relative to invested capital
0.17
Asset turnover ratio
0.39
Inventory turnover ratio
1.76
Receivables turnover ratio
51.13
Average number of days it takes to collect receivables
-29.10
Measures valuation relative to earnings
256.25
P/E based on future earnings estimates
7.61
Measures valuation relative to sales
7.39
Measures valuation relative to book value
-11.95
Measures valuation relative to operating cash flow
-7.19
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
